Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Ryan Thomas Discusses Acquisition for GlobeSt.com

GlobeSt.com

Media Mentions

February 17, 2010

Ryan Thomas, attorney at Bass, Berry & Sims, is extensively quoted regarding an offer by Indianapolis-based Simon Property Group to acquire Chicago-based General Growth Properties, thus merging the top two retail-focused real estate companies in the country. The article by reporter Katie Hinderer, titled "Simon Faces Uphill Battle with Shareholders," appears in the February 17, 2010 online edition of GlobeSt.com.

From the article:

However, this is not a done deal, according to Ryan Thomas, a partner at Bass Berry & Sims PLC and expert in mergers and acquisitions of public and private companies. Since GGP is still trying to pull a number of assets out of bankruptcy, Simon will need court approval; as well as the approval of secured creditors and shareholders.

The creditors may be the easiest challenge. "The court will balance the interests of all creditors, including the secured creditors, and will consider the feasibility of the Simon transaction," Thomas tells GlobeSt.com. "The secured creditors may support the transaction, unless they see an alternate path that enhances their collateral -- or unless the Simon transaction somehow impairs their collateral."

"The shareholders and the board will likely be a challenge for Simon, especially given the apparent cold shoulder to date," Thomas says. "One of General Growth's largest equity holders, (Pershing Square) who happens to be an activist investor, has recently indicated that the company is vastly undervalued -- placing its valuation significantly higher than the offer by Simon. It is also telling that the board has apparently not engaged in negotiations with Simon, presumably reflecting either a more optimistic view of the residual value of the equity or confidence in a better alternative plan."


In Case You Missed It:

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.